1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Denisov, A.Y.
Madiraju, M.S.
Chen, G.
Khadir, A.
Beauparlant, P.
Attardo, G.
Shore, G.C.
Gehring, K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.BIOL.CHEM.
JBCHA3
0071
0021-9258
278
21124
21128
10.1074/jbc.M301798200
12651847
Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix
2003
10.2210/pdb1mk3/pdb
pdb_00001mk3
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
19659.885
Apoptosis regulator Bcl-W
P116V
1
man
polymer
Bcl-w
no
no
ATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQ
VSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEVLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEARR
LREGNWASVRLEHHHHHH
ATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFTQ
VSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEVLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEARR
LREGNWASVRLEHHHHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
9606
Homo sapiens
511693
Escherichia coli BL21
BL21
pET-29b+
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2003-06-03
1
1
2008-04-28
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2002-08-28
REL
REL
The structure was determined using triple-resonance NMR spectroscopy
structures with the least restraint violations,structures with the lowest energy
200
10
HNCACB
CBCA(CO)HN
13C,15N-edited NOESY
HNCO
15N-edited NOESY
HNHA
IPAP-HSQC
10 mM NaCl
7.3
1
atm
298
K
Structure refined by using standard protocol in CNS with restraints from NOE distances, backbone torsion angles, hydrogen bonds and residual dipolar couplings
simulated annealing
1
closest to the average,lowest energy
1.4 mM Bcl-w protein U-15N,13C, 20 mM phosphate buffer
90% H2O/10% D2O
1.3 mM Bcl-w protein U-15N, 20 mM phosphate buffer
90% H2O/10% D2O
0.5 mM Bcl-w protein U-15N, 6 MG/ML PF1-PHAGE
90% H2O/10% D2O
Brunger
collection
CNS
Brunger
processing
CNS
Brunger
data analysis
CNS
Brunger et al.
refinement
CNS
1.1
500
Bruker
DRX
800
Varian
INOVA
ALA
1
n
1
ALA
1
A
THR
2
n
2
THR
2
A
PRO
3
n
3
PRO
3
A
ALA
4
n
4
ALA
4
A
SER
5
n
5
SER
5
A
ALA
6
n
6
ALA
6
A
PRO
7
n
7
PRO
7
A
ASP
8
n
8
ASP
8
A
THR
9
n
9
THR
9
A
ARG
10
n
10
ARG
10
A
ALA
11
n
11
ALA
11
A
LEU
12
n
12
LEU
12
A
VAL
13
n
13
VAL
13
A
ALA
14
n
14
ALA
14
A
ASP
15
n
15
ASP
15
A
PHE
16
n
16
PHE
16
A
VAL
17
n
17
VAL
17
A
GLY
18
n
18
GLY
18
A
TYR
19
n
19
TYR
19
A
LYS
20
n
20
LYS
20
A
LEU
21
n
21
LEU
21
A
ARG
22
n
22
ARG
22
A
GLN
23
n
23
GLN
23
A
LYS
24
n
24
LYS
24
A
GLY
25
n
25
GLY
25
A
TYR
26
n
26
TYR
26
A
VAL
27
n
27
VAL
27
A
CYS
28
n
28
CYS
28
A
GLY
29
n
29
GLY
29
A
ALA
30
n
30
ALA
30
A
GLY
31
n
31
GLY
31
A
PRO
32
n
32
PRO
32
A
GLY
33
n
33
GLY
33
A
GLU
34
n
34
GLU
34
A
GLY
35
n
35
GLY
35
A
PRO
36
n
36
PRO
36
A
ALA
37
n
37
ALA
37
A
ALA
38
n
38
ALA
38
A
ASP
39
n
39
ASP
39
A
PRO
40
n
40
PRO
40
A
LEU
41
n
41
LEU
41
A
HIS
42
n
42
HIS
42
A
GLN
43
n
43
GLN
43
A
ALA
44
n
44
ALA
44
A
MET
45
n
45
MET
45
A
ARG
46
n
46
ARG
46
A
ALA
47
n
47
ALA
47
A
ALA
48
n
48
ALA
48
A
GLY
49
n
49
GLY
49
A
ASP
50
n
50
ASP
50
A
GLU
51
n
51
GLU
51
A
PHE
52
n
52
PHE
52
A
GLU
53
n
53
GLU
53
A
THR
54
n
54
THR
54
A
ARG
55
n
55
ARG
55
A
PHE
56
n
56
PHE
56
A
ARG
57
n
57
ARG
57
A
ARG
58
n
58
ARG
58
A
THR
59
n
59
THR
59
A
PHE
60
n
60
PHE
60
A
SER
61
n
61
SER
61
A
ASP
62
n
62
ASP
62
A
LEU
63
n
63
LEU
63
A
ALA
64
n
64
ALA
64
A
ALA
65
n
65
ALA
65
A
GLN
66
n
66
GLN
66
A
LEU
67
n
67
LEU
67
A
HIS
68
n
68
HIS
68
A
VAL
69
n
69
VAL
69
A
THR
70
n
70
THR
70
A
PRO
71
n
71
PRO
71
A
GLY
72
n
72
GLY
72
A
SER
73
n
73
SER
73
A
ALA
74
n
74
ALA
74
A
GLN
75
n
75
GLN
75
A
GLN
76
n
76
GLN
76
A
ARG
77
n
77
ARG
77
A
PHE
78
n
78
PHE
78
A
THR
79
n
79
THR
79
A
GLN
80
n
80
GLN
80
A
VAL
81
n
81
VAL
81
A
SER
82
n
82
SER
82
A
ASP
83
n
83
ASP
83
A
GLU
84
n
84
GLU
84
A
LEU
85
n
85
LEU
85
A
PHE
86
n
86
PHE
86
A
GLN
87
n
87
GLN
87
A
GLY
88
n
88
GLY
88
A
GLY
89
n
89
GLY
89
A
PRO
90
n
90
PRO
90
A
ASN
91
n
91
ASN
91
A
TRP
92
n
92
TRP
92
A
GLY
93
n
93
GLY
93
A
ARG
94
n
94
ARG
94
A
LEU
95
n
95
LEU
95
A
VAL
96
n
96
VAL
96
A
ALA
97
n
97
ALA
97
A
PHE
98
n
98
PHE
98
A
PHE
99
n
99
PHE
99
A
VAL
100
n
100
VAL
100
A
PHE
101
n
101
PHE
101
A
GLY
102
n
102
GLY
102
A
ALA
103
n
103
ALA
103
A
ALA
104
n
104
ALA
104
A
LEU
105
n
105
LEU
105
A
CYS
106
n
106
CYS
106
A
ALA
107
n
107
ALA
107
A
GLU
108
n
108
GLU
108
A
SER
109
n
109
SER
109
A
VAL
110
n
110
VAL
110
A
ASN
111
n
111
ASN
111
A
LYS
112
n
112
LYS
112
A
GLU
113
n
113
GLU
113
A
MET
114
n
114
MET
114
A
GLU
115
n
115
GLU
115
A
VAL
116
n
116
VAL
116
A
LEU
117
n
117
LEU
117
A
VAL
118
n
118
VAL
118
A
GLY
119
n
119
GLY
119
A
GLN
120
n
120
GLN
120
A
VAL
121
n
121
VAL
121
A
GLN
122
n
122
GLN
122
A
GLU
123
n
123
GLU
123
A
TRP
124
n
124
TRP
124
A
MET
125
n
125
MET
125
A
VAL
126
n
126
VAL
126
A
ALA
127
n
127
ALA
127
A
TYR
128
n
128
TYR
128
A
LEU
129
n
129
LEU
129
A
GLU
130
n
130
GLU
130
A
THR
131
n
131
THR
131
A
ARG
132
n
132
ARG
132
A
LEU
133
n
133
LEU
133
A
ALA
134
n
134
ALA
134
A
ASP
135
n
135
ASP
135
A
TRP
136
n
136
TRP
136
A
ILE
137
n
137
ILE
137
A
HIS
138
n
138
HIS
138
A
SER
139
n
139
SER
139
A
SER
140
n
140
SER
140
A
GLY
141
n
141
GLY
141
A
GLY
142
n
142
GLY
142
A
TRP
143
n
143
TRP
143
A
ALA
144
n
144
ALA
144
A
GLU
145
n
145
GLU
145
A
PHE
146
n
146
PHE
146
A
THR
147
n
147
THR
147
A
ALA
148
n
148
ALA
148
A
LEU
149
n
149
LEU
149
A
TYR
150
n
150
TYR
150
A
GLY
151
n
151
GLY
151
A
ASP
152
n
152
ASP
152
A
GLY
153
n
153
GLY
153
A
ALA
154
n
154
ALA
154
A
LEU
155
n
155
LEU
155
A
GLU
156
n
156
GLU
156
A
GLU
157
n
157
GLU
157
A
ALA
158
n
158
ALA
158
A
ARG
159
n
159
ARG
159
A
ARG
160
n
160
ARG
160
A
LEU
161
n
161
LEU
161
A
ARG
162
n
162
ARG
162
A
GLU
163
n
163
GLU
163
A
GLY
164
n
164
GLY
164
A
ASN
165
n
165
ASN
165
A
TRP
166
n
166
TRP
166
A
ALA
167
n
167
ALA
167
A
SER
168
n
168
SER
168
A
VAL
169
n
169
VAL
169
A
ARG
170
n
170
ARG
170
A
LEU
171
n
171
LEU
171
A
GLU
172
n
172
GLU
172
A
HIS
173
n
173
HIS
173
A
HIS
174
n
174
HIS
174
A
HIS
175
n
175
HIS
175
A
HIS
176
n
176
HIS
176
A
HIS
177
n
177
HIS
177
A
HIS
178
n
178
HIS
178
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
HA
HD11
GLN
LEU
75
105
1.33
3
A
A
O
H
PHE
GLY
86
89
1.58
5
A
A
HB2
HG2
PHE
ARG
86
94
1.26
5
A
A
O
H
VAL
GLU
110
113
1.59
5
A
A
O
H
PHE
GLY
86
89
1.59
6
A
A
H
HE
SER
ARG
73
77
1.25
6
A
A
HB3
HB3
ARG
ARG
55
159
1.32
6
A
A
HB2
HG3
PHE
ARG
86
94
1.33
6
A
A
O
HG1
ALA
THR
127
131
1.58
6
A
A
O
H
VAL
GLU
110
113
1.59
7
A
A
HH12
HA
ARG
ARG
94
162
1.21
7
A
A
HG3
H
ARG
ARG
159
160
1.34
8
A
A
HB3
HB3
ARG
ARG
55
159
1.22
8
A
A
HH21
HG2
ARG
ARG
55
162
1.22
8
A
A
HA
HD23
PHE
LEU
146
149
1.34
10
A
A
O
H
PHE
GLY
86
89
1.57
1
A
PRO
7
-51.72
176.07
1
A
PRO
40
-70.47
43.26
1
A
PHE
56
-86.68
-135.88
1
A
ARG
57
-139.57
-77.45
1
A
PHE
60
-65.03
-71.03
1
A
ALA
64
-65.57
-71.92
1
A
HIS
68
-59.21
-75.01
1
A
THR
70
-50.90
108.69
1
A
ALA
74
-72.72
-155.63
1
A
GLN
87
-46.90
81.92
1
A
PRO
90
-71.82
40.50
1
A
ALA
97
-75.50
-74.48
1
A
MET
114
-100.48
43.36
1
A
ARG
160
-39.19
-34.21
1
A
SER
168
-70.88
25.77
1
A
LEU
171
-122.97
-162.26
1
A
HIS
173
-63.73
-171.15
2
A
PRO
3
-51.74
109.65
2
A
PRO
7
-51.72
104.95
2
A
TYR
26
-145.53
-61.99
2
A
PRO
36
-53.49
107.41
2
A
PRO
40
-68.58
15.68
2
A
PHE
56
-91.28
-139.63
2
A
ARG
57
-140.47
-75.95
2
A
PHE
60
-56.86
-70.80
2
A
ASP
62
-55.30
-74.34
2
A
HIS
68
-52.21
-73.36
2
A
THR
70
-54.71
108.13
2
A
PRO
71
-49.51
102.16
2
A
ALA
74
-71.12
-154.17
2
A
GLN
87
-47.06
81.89
2
A
PRO
90
-71.88
39.10
2
A
PHE
101
-63.16
-71.99
2
A
LYS
112
-66.43
1.67
2
A
MET
114
-100.73
44.92
2
A
THR
131
-78.98
-73.86
2
A
TYR
150
-89.45
32.57
2
A
SER
168
-66.46
14.60
2
A
HIS
174
-108.33
-167.73
2
A
HIS
177
-116.62
-169.29
3
A
PRO
3
-53.55
-75.67
3
A
VAL
27
-56.49
91.18
3
A
PHE
56
-92.01
-145.37
3
A
ARG
57
-140.23
-78.18
3
A
PHE
60
-39.50
-71.52
3
A
ASP
62
-59.02
-74.79
3
A
ALA
64
-59.36
-71.83
3
A
HIS
68
-54.60
-73.38
3
A
VAL
69
-29.73
-65.02
3
A
THR
70
-50.28
109.78
3
A
PRO
71
-49.39
101.88
3
A
ALA
74
-72.21
-149.55
3
A
GLN
87
-46.08
81.54
3
A
PRO
90
-71.01
44.59
3
A
ALA
97
-67.54
-70.70
3
A
PHE
98
-39.80
-33.99
3
A
THR
131
-78.98
-73.98
3
A
TYR
150
-89.73
30.00
3
A
ARG
159
-53.20
-73.35
3
A
ARG
160
-39.59
-32.98
4
A
VAL
13
-63.71
-70.18
4
A
VAL
17
-68.35
-70.35
4
A
ALA
30
-124.35
-69.56
4
A
ALA
38
-86.79
37.94
4
A
LEU
41
-68.15
-70.01
4
A
PHE
56
-92.08
-141.33
4
A
ARG
57
-140.70
-90.20
4
A
SER
61
-56.71
-75.10
4
A
HIS
68
-51.68
-72.00
4
A
THR
70
-45.18
108.73
4
A
PRO
71
-51.79
104.19
4
A
ALA
74
-70.03
-153.59
4
A
GLN
87
-42.26
81.58
4
A
PRO
90
-72.34
33.19
4
A
ALA
97
-66.68
-72.49
4
A
LYS
112
-63.99
4.88
4
A
MET
114
-99.78
42.69
4
A
THR
131
-78.64
-73.09
4
A
ARG
159
-56.86
-76.00
4
A
ARG
160
-38.66
-32.45
4
A
HIS
174
-56.42
-174.68
5
A
PRO
32
-70.77
28.16
5
A
PRO
40
-70.25
41.31
5
A
PHE
56
-91.88
-142.73
5
A
ARG
57
-141.63
-91.08
5
A
PHE
60
-39.18
-70.40
5
A
VAL
69
-29.47
-63.40
5
A
THR
70
-49.86
108.31
5
A
PRO
71
-54.15
91.94
5
A
ALA
74
-67.71
-151.83
5
A
GLN
87
-43.24
81.22
5
A
PRO
90
-68.90
39.24
5
A
VAL
110
-57.82
-71.03
5
A
MET
114
-107.05
60.34
5
A
THR
131
-83.56
-70.02
5
A
TYR
150
-91.54
36.21
5
A
GLU
157
-59.96
-74.19
5
A
ARG
159
-51.14
-79.77
5
A
ARG
170
-59.68
-176.23
6
A
PRO
3
-52.83
-168.92
6
A
ALA
6
-116.18
69.68
6
A
VAL
27
-59.97
93.05
6
A
ALA
30
-103.06
-166.33
6
A
PHE
56
-89.18
-140.31
6
A
ARG
57
-135.89
-82.29
6
A
ARG
58
-117.63
62.91
6
A
ASP
62
-63.92
-71.19
6
A
HIS
68
-66.81
-76.86
6
A
VAL
69
-29.56
-58.78
6
A
ALA
74
-70.48
-156.53
6
A
GLN
87
-44.85
82.22
6
A
PRO
90
-69.84
40.08
6
A
MET
114
-104.17
58.88
6
A
SER
168
-69.49
21.43
6
A
VAL
169
-46.07
98.06
6
A
ARG
170
-81.22
-81.66
7
A
PRO
3
-52.95
103.05
7
A
PRO
7
-51.13
177.04
7
A
GLU
34
-90.96
50.48
7
A
ALA
38
-78.86
23.40
7
A
PRO
40
-68.70
90.43
7
A
PHE
56
-88.49
-140.98
7
A
ARG
57
-141.65
-74.79
7
A
PHE
60
-44.99
-70.39
7
A
VAL
69
-29.95
-66.61
7
A
THR
70
-41.68
109.84
7
A
PRO
71
-49.48
95.70
7
A
ALA
74
-69.69
-151.47
7
A
GLN
87
-46.02
82.22
7
A
MET
114
-102.46
55.27
7
A
SER
168
-82.57
36.67
7
A
HIS
175
-61.17
-163.19
7
A
HIS
177
-58.75
107.62
8
A
PHE
56
-89.03
-137.91
8
A
ARG
57
-136.81
-61.36
8
A
PHE
60
-66.57
-70.16
8
A
HIS
68
-61.64
-79.39
8
A
SER
73
-69.40
-173.76
8
A
ALA
74
-67.77
-156.76
8
A
GLN
87
-40.34
80.80
8
A
PRO
90
-73.29
34.46
8
A
ALA
97
-67.56
-70.24
8
A
PHE
101
-61.52
-74.82
8
A
MET
114
-101.91
52.04
8
A
SER
168
-63.13
2.56
8
A
VAL
169
-81.38
38.16
9
A
PRO
7
-51.28
105.07
9
A
GLN
23
-72.32
20.44
9
A
PHE
56
-90.80
-138.87
9
A
ARG
57
-139.61
-72.98
9
A
THR
59
-39.90
-31.19
9
A
ASP
62
-68.91
-70.15
9
A
HIS
68
-62.18
-75.02
9
A
PRO
71
-56.13
91.37
9
A
ALA
74
-67.61
-159.45
9
A
GLN
87
-45.16
82.18
9
A
PRO
90
-69.11
52.10
9
A
MET
114
-100.72
41.67
9
A
THR
131
-79.81
-71.62
9
A
GLU
157
-59.28
-71.37
9
A
ARG
159
-50.02
-78.51
9
A
ARG
160
-39.55
-31.81
9
A
SER
168
-67.62
14.60
9
A
HIS
173
-63.47
-168.91
9
A
HIS
176
-53.12
105.37
10
A
PRO
32
-71.48
30.05
10
A
PRO
40
-69.24
3.25
10
A
PHE
56
-91.51
-143.37
10
A
ARG
57
-140.70
-81.83
10
A
PHE
60
-42.28
-70.80
10
A
VAL
69
-29.89
-63.69
10
A
THR
70
-54.51
107.00
10
A
PRO
71
-50.05
92.23
10
A
ALA
74
-67.02
-153.75
10
A
GLN
87
-43.92
80.97
10
A
PRO
90
-70.79
43.70
10
A
ALA
97
-70.94
-70.53
10
A
MET
114
-100.71
53.55
10
A
THR
131
-79.64
-73.21
10
A
TYR
150
-90.20
35.10
10
A
GLU
157
-62.59
-71.40
10
A
ARG
159
-53.39
-77.58
10
A
HIS
174
-106.72
-167.30
SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN
1
N
N
A
ASP
8
A
ASP
8
HELX_P
A
GLN
23
A
GLN
23
1
1
16
A
PRO
40
A
PRO
40
HELX_P
A
PHE
56
A
PHE
56
1
2
17
A
ARG
58
A
ARG
58
HELX_P
A
THR
70
A
THR
70
1
3
13
A
ALA
74
A
ALA
74
HELX_P
A
GLN
87
A
GLN
87
1
4
14
A
TRP
92
A
TRP
92
HELX_P
A
LYS
112
A
LYS
112
1
5
21
A
MET
114
A
MET
114
HELX_P
A
ARG
132
A
ARG
132
1
6
19
A
LEU
133
A
LEU
133
HELX_P
A
GLY
141
A
GLY
141
1
7
9
A
GLY
142
A
GLY
142
HELX_P
A
ALA
148
A
ALA
148
1
8
7
A
ALA
154
A
ALA
154
HELX_P
A
SER
168
A
SER
168
1
9
15
APOPTOSIS
Bcl-w protein, apoptotis, APOPTOSIS
BCLW_HUMAN
UNP
1
1
Q92843
MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFT
QVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVGQVQEWMVAYLETRLADWIHSSGGWAEFTALYGDGALEEAR
RLREGNWASVR
2
171
1MK3
1
170
Q92843
A
1
1
170
1
PRO
engineered mutation
VAL
116
1MK3
A
Q92843
UNP
117
116
1
expression tag
LEU
171
1MK3
A
Q92843
UNP
171
1
expression tag
GLU
172
1MK3
A
Q92843
UNP
172
1
expression tag
HIS
173
1MK3
A
Q92843
UNP
173
1
expression tag
HIS
174
1MK3
A
Q92843
UNP
174
1
expression tag
HIS
175
1MK3
A
Q92843
UNP
175
1
expression tag
HIS
176
1MK3
A
Q92843
UNP
176
1
expression tag
HIS
177
1MK3
A
Q92843
UNP
177
1
expression tag
HIS
178
1MK3
A
Q92843
UNP
178